ShoreHaven Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-649
Closed -$48K – 181
2021
Q1
$48K Buy
649
+232
+56% +$17.1K 0.03% 118
2020
Q4
$33K Buy
+417
New +$31.9K 0.02% 131

Other funds holding MRK

ShoreHaven Wealth Partners's MRK Position: Q2 2021 in Review

ShoreHaven Wealth Partners sold out of Merck (MRK) in Q2 2021, closing a stake of 649 shares — an estimated $48K sold.

ShoreHaven Wealth Partners first reported a position in MRK in Q4 2020 and held it in 2 quarters. The position peaked at $48K in Q1 2021. 2,675 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • ShoreHaven Wealth Partners reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • ShoreHaven Wealth Partners sold 649 Merck shares in Q2 2021, an estimated $48K.
  • ShoreHaven Wealth Partners first reported a position in Merck in Q4 2020 and held it in 2 quarters.
  • ShoreHaven Wealth Partners's Merck position peaked at $48K in Q1 2021.
  • 2,675 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on ShoreHaven Wealth Partners's 13F filing for Q2 2021, filed 16 Aug 2021.